Treatment of allergic rhinitis: An evidence-based evaluation of nasal corticosteroids versus nonsedating antihistamines

American Journal of Managed Care

Volumn 4, Issue 1, 1998, Pages 89-96

  Stempel, David A ^a   Thomas, Michael ^b  

^a VIRGINIA MASON MEDICAL CENTER   (United States)

^b Priority Statistics   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHISTAMINIC AGENT; ASTEMIZOLE; BECLOMETASONE; CORTICOSTEROID; FLUTICASONE; LORATADINE; MOMETASONE FUROATE; TERFENADINE; TRIAMCINOLONE;

ALLERGIC RHINITIS; ARTICLE; COST BENEFIT ANALYSIS; DRUG COST; DRUG EFFICACY; HEALTH CARE COST; HUMAN; INFLAMMATORY DISEASE; INTRANASAL DRUG ADMINISTRATION; PREVALENCE; PRIORITY JOURNAL; PRODUCTIVITY; QUALITY OF LIFE; STATISTICAL ANALYSIS;

ADMINISTRATION, INTRANASAL; ADRENAL CORTEX HORMONES; COST OF ILLNESS; DATA COLLECTION; DRUG COSTS; DRUG UTILIZATION; EVIDENCE-BASED MEDICINE; HISTAMINE H1 ANTAGONISTS; HUMANS; OUTCOME ASSESSMENT (HEALTH CARE); QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIALS; RHINITIS, ALLERGIC, SEASONAL; UNITED STATES;

EID: 0031926826     PISSN: 10880224     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Druce HM. Allergic and nonallergic rhinitis. In: Middleton E Jr, Reed CE, Ellis EF, Adkinson NF Jr, Yuninger JW, Busse WW, eds. Allergy: Principles and Practice. 4th ed. St Louis: Mosby, 1993:1433-1453.
2. Sibbald B, Rink E. Epidemiology of seasonal and perennial rhinitis: Clinical presentation and medical history. Thorax 1991;46:895-901.
3. deShazo RD. Allergic rhinitis. In: Bennett JC, Plum F, eds. Cecil Textbook of Medicine. 20th ed. Philadelphia: WB Saunders, 1996:413-417.
4. Williams LW. Allergic rhinitis and conjunctivitis. In: Rudolph AM, Hoffman JIE, Rudolph CD, eds. Rudolph's Pediatrics. 20th ed. Stamford, CT.: Appleton & Lange, 1996:459-461.
5. Malone DC, Lawson KA, Smith DH, Arrighi HM, Battista C. A cost of illness study of allergic rhinitis in the United States. J Allergy Clin Immunol 1997;99:22-27.
6. McMenamin P. Costs of hayfever in the United States in 1990. Ann Allergy 1994;73:35-39.
7. Ross RN. The costs of allergic rhinitis. Am J Man Care 1996;2:285-290.
8. Bousquet J, Bullinger M, Fayol C, Marquis P, Valentin B, Burtin B. Assessment of quality of life in patients with perennial allergic rhinitis with the French version of the SF-36 health status questionnaire. J Allergy Clin Immunol 1994;94:182-188.
9. Sibbald B, Hilton S, D'Souza M. An open cross-over trial comparing two doses of astemizole and beclomethasone dipropionate in the treatment of perennial rhinitis. Clin Allergy 1986;16:203-211.
10. Robinson AC, Cherry JR, Daly S. Double-blind cross-over trial comparing beclomethasone dipropionate and terfenadine in perennial rhinitis. Clin Exp Allergy 1989;19:569-573.
11. Lau SK, Wei WI, Van Hasselt CA, et al. A clinical comparison of budesonide nasal aerosol, terfenadine and a combined therapy of budesonide and oxymetazoline in adult patients with perennial rhinitis. Asian Pac J Allergy Immunol 1990;8:109-115.
12. Negrini AC, Troise C, Voltolini S, et al. Oral antihistamine/decongestant treatment compared with intranasal corticosteroids in seasonal allergic rhinitis. Clin Exp Allergy 1995;25:60-65.
13. Hilberg O. Effect of terfenadine and budesonide on nasal symptoms, olfaction, and nasal airway patency following allergen challenge. Allergy 1995;50:683-686.
14. Wood SF. Oral antihistamine or nasal steroid in hay fever: A double blind-double-dummy comparative study of once-daily oral astemizole vs twice daily nasal beclomethasone dipropionate. Clin Allergy 1986;16:195-201.
15. Bernstein DI, Creticos PG, Busse WW, et al. Comparison of triamcinolone acetonide nasal inhaler with astemizole in the treatment of ragweed-induced allergic rhinitis. J Allergy Clin Immunol 1996;97:749-755.
16. Bunnag C, Jareoncharsri P, Wong ECK. A double-blind comparison of nasal budesonide and oral astemizole for the treatment of perennial rhinitis. Allergy 1992;47:313-317.
17. Darnell R, Pecoud A, Richards DH. A double-blind comparison of fluticasone propionate aqueous nasal spray, terfenadine tablets and placebo in the treatment of patients with seasonal allergic rhinitis to grass pollen. Clin Exp Allergy 1994;24:1144-1150.
18. Frølund L. Efficacy of an oral antihistamine, loratadine, as compared with a nasal steroid spray, beclomethasone dipropionate, in seasonal allergic rhinitis. Clin Otolaryngol 1991;16:527-531.
19. Jordana G, Dolovich J, Briscoe MP, et al. Intranasal fluticasone propionate versus loratadine in the treatment of adolescent patients with seasonal allergic rhinitis. J Allergy Clin Immunol 1996;97:588-595.
20. Juniper EF, Kline PA, Hargreave FE, et al. Comparison of beclomethasone diproprionate aqueous nasal spray, astemizole, and the combination in the prophylactic treatment of ragweed pollen-induced rhinoconjunctivitis. J Allergy Clin Immunol 1989;83:627-633.
21. Salomonsson P, Gottberg L, Heilborn H, et al. Efficacy of an oral antihistamine, astemizole, as compared to a nasal steroid spray in hay fever. Allergy 1988;43:21421-8.
22. Schenkel EJ, Nolop K, Mesarina-Wicki B. Evaluation of mometasone furcate nasal spray with the addition of loratadine vs placebo in the treatment of seasonal allergic rhinitis. Ann Allergy Asthma Immunol 1997;78:126. Abstract.
23. Schoenwetter W, Lim J. Comparison of intranasal triamcinolone acetonide with oral loratadine for the treatment of patients with seasonal allergic rhinitis. Clin Ther 1995;17: 479-492.
24. Simpson RJ. Budesonide and terfenadine, separately and in combination, in the treatment of hayfever. Ann Allergy 1994;73:497-502.
25. Bronsky E, Boggs P, Findlay S, et al. Comparative efficacy and safety of a once-daily loratadine-pseudoephedrine combination versus its components alone and placebo in the management of seasonal allergic rhinitis. J Allergy Clin Immunol 1995;96:139-147.
26. Ratner PH, van Bavel JH, Martin BG, et al. The efficacy and safety of fluticasone propionate aqueous nasal spray and loratadine, alone and in combination, in the treatment of seasonal allergic rhinitis. J Allergy Clin Immunol 1997; 99:S439. Abstract.
27. van Bavel J, Findlay SR, Hampel FC, Martin BG, Ratner P, Field E. Intranasal fluticasone propionate is more effective than terfenadine tablets for seasonal allergic rhinitis. Arch Intern Med 1994;154:2699-2704.
28. Wiseman LR, Benfield P. Intranasal fluticasone propionate: A reappraisal of its pharmacology and clinical efficacy in the treatment of rhinitis. Drugs 1997;55:885-907.
29. Simons FSR. New medications for rhinitis. In: Busse WW, Holgate ST, eds. Asthma and Allergy. Boston: Blackwell Scientific, 1995:1325-1336.
30. Bowers B, Cox F, Howland W, Cook C, Westlund R, Rogenes P. Superior impact of intranasal fluticasone vs loratadine on work, home and leisure activities affected by SAR. J Allergy Clin Immunol 1997;99:S439. Abstract.
31. Gilmore TM, Alexander BH, Mueller BA, Rivara FP. Occupational injuries and mediation use. Am J Ind Med 1996;30:234-239.
32. Berks C, Chin W. Fluticasone propionate intranasal steroid: Cost effectiveness versus antihistamines. J Allergy Clin Immunol 1994;93:165.
33. Goodwin B, Bowers B, Hampel F, Cook C, Westlund R, Cox F. Superior improvement in disease-specific quality of life for SAR patients receiving intranasal fluticasone vs loratadine tablets. J Allergy Clin Immunol 1997;99: S270.Abstract.
34. Creticos PS. Allergic rhinitis. In: Busse WW, Holgate ST, eds. Asthma and Allergy. Boston: Blackwell Scientific, 1995:1394-1414.
35. Expert Panel Report II. Guidelines for the diagnosis and management of asthma. Bethesda, MD; 1997. NIH publication 97-4051.
36. Berwick DM. Payment by capitation and the quality of care. N Engl J Med 1996;335:1227-1231.